Roxane Agrees To Delay Launch Of Generic Asacol

Law360, New York (February 23, 2011, 1:34 PM EST) -- A federal judge on Tuesday put a patent infringement suit over inflammatory bowel disorder drug Asacol on hold, following defendant generic-drug maker Roxane Laboratories Inc.’s agreement to delay the launch of a generic version of the drug until September.

Judge Freda L. Wolfson of the U.S. District Court for the District of New Jersey signed off on a stipulated order of administrative closure with leave to reopen the case brought by Medeva Pharma Suisse AG and Warner Chilcott Pharmaceuticals Inc.

Judge Wolfson ordered this closure at...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.